{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:55:57Z","timestamp":1761396957997,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06127-7","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T04:32:34Z","timestamp":1732941154000},"page":"5985-5988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pyoderma gangrenosum-like neutrophilic dermatosis as an adverse effect of menin-KMT2A inhibitor therapy for acute myeloid leukaemia"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-1486-9873","authenticated-orcid":false,"given":"Urbain","family":"Tauveron-Jalenques","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadim","family":"Sarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Gui\u00e8ze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chlo\u00e9","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Rouanet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandrine","family":"Hayette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carole","family":"Chevenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u00ebl","family":"Heiblig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Ravinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"issue":"4","key":"6127_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro R, Duggal G, Love MI et al (2017) Salmon provides fast and bias-aware quantification of transcript expression. Nat Methods 14(4):417\u2013419. https:\/\/doi.org\/10.1038\/nmeth.4197","journal-title":"Nat Methods"},{"issue":"7954","key":"6127_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/s41586-023-05812-3","volume":"615","author":"GC Issa","year":"2023","unstructured":"Issa GC, Aldoss I, DiPersio J et al (2023) The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature 615(7954):920\u2013924. https:\/\/doi.org\/10.1038\/s41586-023-05812-3","journal-title":"Nature"},{"issue":"Supplement 1","key":"6127_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1182\/blood-2023-172422","volume":"142","author":"E Jabbour","year":"2023","unstructured":"Jabbour E, Searle E, Abdul-Hay M et al (2023) A first-in-human phase 1 study of the Menin-KMT2A (MLL1) inhibitor JNJ-75276617 in adult patients with Relapsed\/Refractory Acute Leukemia Harboring KMT2A or NPM1 alterations. Blood 142(Supplement 1):57 Oral abstract presentation, 65th ASH annual meeting and exposition, San Diego, California, 2023","journal-title":"Blood"},{"key":"6127_CR4","doi-asserted-by":"publisher","unstructured":"Issa GC, Aldoss I, Thirman MJ et al Menin Inhibition with Revumenib for KMT2A-Rearranged relapsed or refractory Acute Leukemia (AUGMENT-101). J Clin Oncol 2024 Aug 9:JCO2400826. https:\/\/doi.org\/10.1200\/JCO.24.00826","DOI":"10.1200\/JCO.24.00826"},{"issue":"4","key":"6127_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.7326\/0003-4819-117-4-292","volume":"117","author":"SR Frankel","year":"1992","unstructured":"Frankel SR, Eardley A, Lauwers G et al (1992) The retinoic acid syndrome in acute promyelocytic leukemia. Ann Intern Med 117(4):292\u2013296. https:\/\/doi.org\/10.7326\/0003-4819-117-4-292","journal-title":"Ann Intern Med"},{"issue":"2","key":"6127_CR6","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00277-001-0416-5","volume":"81","author":"L Astudillo","year":"2002","unstructured":"Astudillo L, Loche F, Reynish W et al (2002) Sweet\u2019s syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia. Ann Hematol 81(2):111\u2013114. https:\/\/doi.org\/10.1007\/s00277-001-0416-5","journal-title":"Ann Hematol"},{"issue":"5","key":"6127_CR7","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1345\/aph.1H563","volume":"41","author":"DF Thompson","year":"2007","unstructured":"Thompson DF, Montarella KE (2007) Drug-induced Sweet\u2019s syndrome. Ann Pharmacother 41(5):802\u2013811. https:\/\/doi.org\/10.1345\/aph.1H563","journal-title":"Ann Pharmacother"},{"issue":"9","key":"6127_CR8","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/jid.2012.130","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Groves RW, Card TR et al (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132(9):2166\u20132170. https:\/\/doi.org\/10.1038\/jid.2012.130","journal-title":"J Invest Dermatol"},{"issue":"4","key":"6127_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s40257-018-0356-7","volume":"19","author":"K Kridin","year":"2018","unstructured":"Kridin K, Cohen AD, Amber KT (2018) Underlying systemic diseases in Pyoderma Gangrenosum: a systematic review and Meta-analysis. Am J Clin Dermatol 19(4):479\u2013487. https:\/\/doi.org\/10.1007\/s40257-018-0356-7","journal-title":"Am J Clin Dermatol"},{"issue":"4","key":"6127_CR10","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/jid.2012.408","volume":"133","author":"P Sujobert","year":"2013","unstructured":"Sujobert P, Cuccuini W, Vignon-Pennamen D et al (2013) Evidence of differentiation in myeloid malignancies associated neutrophilic dermatosis: a fluorescent in situ hybridization study of 14 patients. J Invest Dermatol 133(4):1111\u20131114. https:\/\/doi.org\/10.1038\/jid.2012.408","journal-title":"J Invest Dermatol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06127-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:15:44Z","timestamp":1735866944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6127"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06127-7","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"12 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is in accordance with the ethical standards of our institution and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}